New immunotherapy combination shows promise for patients with advanced melanoma
Treatment with a combination of ipilimumab (Yervoy) and Coxsackievirus A21 (CVA21; Cavatak) led to durable…
Browsing: Yervoy
AACR 2017: Combination of nivolumab and ipilimumab improved overall survival for advanced melanoma patients
Among patients with advanced melanoma, those who received both nivolumab (Opdivo) and ipilimumab (Yervoy) had…
The fourth pillar
The fourth pillar: how we’re arming the immune system to help fight cancer By Joseph Trapani, Peter…